Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 08:46 am Purchase | 2022-12-31 | 13G | Myriad Genetics, Inc. MYGN | Camber Capital Management LP | 7,000,000 8.640% | 2,300,000 (+48.94%) | Filing History |
| 2023-02-09 11:27 am Purchase | 2022-12-30 | 13G | Myriad Genetics, Inc. MYGN | The Vanguard Group | 9,311,761 11.490% | 162,240 (+1.77%) | Filing History |
| 2023-02-06 2:53 pm Purchase | 2022-12-30 | 13G | Myriad Genetics, Inc. MYGN | Wellington Management Group LLP | 6,787,223 8.380% | 2,461,448 (+56.90%) | Filing History |
| 2023-01-31 09:19 am Purchase | 2022-12-31 | 13G | Myriad Genetics, Inc. MYGN | STATE STREET CORP STT | 5,020,423 6.200% | 610,020 (+13.83%) | Filing History |
| 2023-01-23 3:52 pm Sale | 2022-12-31 | 13G | Myriad Genetics, Inc. MYGN | BlackRock Inc. BLK | 14,356,099 17.700% | -328,688 (-2.24%) | Filing History |
| 2023-01-09 5:09 pm Sale | 2022-12-31 | 13G | Myriad Genetics, Inc. MYGN | EARNEST PARTNERS LLC | 3,304,456 4.100% | -3,011,909 (-47.68%) | Filing History |
| 2022-05-12 4:06 pm Purchase | 2022-05-02 | 13G | Myriad Genetics, Inc. MYGN | Camber Capital Management LP | 4,700,000 5.850% | 1,950,000 (+70.91%) | Filing History |
| 2022-02-14 09:39 am Sale | 2021-12-31 | 13G | Myriad Genetics, Inc. MYGN | Camber Capital Management LP | 2,750,000 3.440% | -2,250,000 (-45.00%) | Filing History |
| 2022-02-11 3:19 pm Purchase | 2021-12-31 | 13G | Myriad Genetics, Inc. MYGN | STATE STREET CORP STT | 4,410,403 5.520% | 694,873 (+18.70%) | Filing History |
| 2022-02-10 5:37 pm Sale | 2021-12-31 | 13G | Myriad Genetics, Inc. MYGN | EARNEST PARTNERS LLC | 6,316,365 7.900% | -415,064 (-6.17%) | Filing History |
| 2022-02-10 08:27 am Purchase | 2021-12-31 | 13G | Myriad Genetics, Inc. MYGN | The Vanguard Group | 9,149,521 11.460% | 852,657 (+10.28%) | Filing History |
| 2022-02-04 09:21 am Purchase | 2021-12-31 | 13G | Myriad Genetics, Inc. MYGN | Wellington Management Group LLP | 4,325,775 5.420% | 952,575 (+28.24%) | Filing History |
| 2022-01-27 1:59 pm Unchanged | 2021-12-31 | 13G | Myriad Genetics, Inc. MYGN | BlackRock Inc. BLK | 14,684,787 18.400% | 0 (Unchanged) | Filing History |
| 2022-01-25 6:45 pm Purchase | 2021-12-31 | 13G | Myriad Genetics, Inc. MYGN | BlackRock Inc. BLK | 14,684,787 18.400% | 2,182,867 (+17.46%) | Filing History |
| 2021-02-16 4:03 pm Sale | 2020-12-31 | 13G | Myriad Genetics, Inc. MYGN | D. E. Shaw & Co., L.P. | 3,215,449 4.300% | -576,079 (-15.19%) | Filing History |
| 2021-02-16 3:33 pm Purchase | 2020-12-31 | 13G | Myriad Genetics, Inc. MYGN | EARNEST PARTNERS LLC | 6,731,429 9.000% | 6,731,429 (New Position) | Filing History |
| 2021-02-16 08:20 am Purchase | 2020-12-31 | 13G | Myriad Genetics, Inc. MYGN | Camber Capital Management LP | 5,000,000 6.650% | 1,000,000 (+25.00%) | Filing History |
| 2021-02-16 08:19 am Sale | 2020-12-31 | 13G | Myriad Genetics, Inc. MYGN | STATE STREET CORP STT | 3,715,530 4.940% | -170,746 (-4.39%) | Filing History |
| 2021-02-10 11:28 am Sale | 2020-12-31 | 13G | Myriad Genetics, Inc. MYGN | The Vanguard Group | 8,296,864 11.030% | -23,710 (-0.28%) | Filing History |
| 2021-01-25 4:49 pm Sale | 2020-12-31 | 13G | Myriad Genetics, Inc. MYGN | BlackRock Inc. BLK | 12,501,920 16.600% | -250,199 (-1.96%) | Filing History |